CytRx Corp. (CYTR) To Sell 675K Common Back to RXi Pharma (RXII); CYTR to Receive $3.8M in Deal
Tweet Send to a Friend
CytRx Corporation (NASDAQ: CYTR) today announced that it has entered into a definitive agreement with RXi Pharmaceuticals Corporation (NASDAQ: RXII) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
